| 000 | 01118 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513022237.0 | ||
| 264 | 0 | _c19800627 | |
| 008 | 198006s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1980.tb04854.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcInnes, G T | |
| 245 | 0 | 0 |
_aThe active constituent of spironolactone after acute administration in man [proceedings]. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cMar 1980 |
||
| 300 |
_a295P-296P p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aSpironolactone _xmetabolism |
| 700 | 1 | _aAsbury, M J | |
| 700 | 1 | _aShelton, J R | |
| 700 | 1 | _aHarrison, I R | |
| 700 | 1 | _aRamsay, L E | |
| 700 | 1 | _aVenning, G R | |
| 700 | 1 | _aClarke, J M | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 9 _gno. 3 _gp. 295P-296P |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1980.tb04854.x _zAvailable from publisher's website |
| 999 |
_c7362260 _d7362260 |
||